Variant report

Variant	nsv541801
Chromosome Location	chr13:63736333-64287558
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr13:63818314-63818408	HepG2	liver:	n/a	n/a
2	ARID3A	chr13:63740419-63740523	HepG2	liver:	n/a	n/a
3	ATF2	chr13:63758870-63759176	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr13:63805105-63805108	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr13:63977977-63978197	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr13:64202454-64202872	GM12878	blood:	n/a	n/a
7	BRCA1	chr13:64159675-64159893	Hela-S3	cervix:	n/a	n/a
8	BRCA1	chr13:64009796-64010460	Hela-S3	cervix:	n/a	n/a
9	BRCA1	chr13:63778099-63778105	GM12878	blood:	n/a	n/a
10	CEBPB	chr13:64185838-64186198	IMR90	lung:	n/a	chr13:64186008-64186019
11	CEBPB	chr13:64055471-64055775	ECC-1	luminal epithelium:	n/a	n/a
12	CEBPB	chr13:63995189-63995834	HepG2	liver:	n/a	chr13:63995336-63995347 chr13:63995317-63995329
13	CEBPB	chr13:64195329-64195710	HepG2	liver:	n/a	chr13:64195563-64195576 chr13:64195560-64195577 chr13:64195565-64195576
14	CEBPB	chr13:63845846-63845938	HepG2	liver:	n/a	chr13:63845885-63845896 chr13:63845859-63845870
15	CEBPB	chr13:64034918-64035211	IMR90	lung:	n/a	n/a
16	CEBPB	chr13:64062978-64063157	HepG2	liver:	n/a	chr13:64063058-64063069 chr13:64063057-64063070
17	CEBPB	chr13:64189343-64189719	IMR90	lung:	n/a	n/a
18	CEBPB	chr13:63930210-63930532	HepG2	liver:	n/a	chr13:63930386-63930403 chr13:63930389-63930400
19	CEBPB	chr13:64055395-64055821	ECC-1	luminal epithelium:	n/a	n/a
20	CEBPB	chr13:63995204-63995649	IMR90	lung:	n/a	chr13:63995336-63995347 chr13:63995317-63995329
21	CEBPB	chr13:64198975-64199225	A549	lung:	n/a	chr13:64199079-64199090 chr13:64199079-64199090 chr13:64199080-64199091
22	CEBPB	chr13:63915756-63915823	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPB	chr13:64072043-64072243	HepG2	liver:	n/a	n/a
24	CEBPB	chr13:64282710-64282910	H1-hESC	embryonic stem cell:	n/a	chr13:64282778-64282789 chr13:64282778-64282791 chr13:64282779-64282790
25	CEBPB	chr13:64282631-64282951	HepG2	liver:	n/a	chr13:64282778-64282789 chr13:64282778-64282791 chr13:64282779-64282790
26	CEBPB	chr13:63878680-63878955	A549	lung:	n/a	chr13:63878814-63878825
27	CEBPB	chr13:63740261-63740628	IMR90	lung:	n/a	chr13:63740443-63740452 chr13:63740441-63740454 chr13:63740441-63740452
28	CEBPB	chr13:63878620-63878978	IMR90	lung:	n/a	chr13:63878814-63878825
29	CEBPB	chr13:63869759-63870039	IMR90	lung:	n/a	chr13:63869907-63869918 chr13:63869907-63869920
30	CEBPB	chr13:64044428-64044734	IMR90	lung:	n/a	n/a
31	CEBPB	chr13:64009623-64010436	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr13:63930261-63930499	A549	lung:	n/a	chr13:63930386-63930403 chr13:63930389-63930400
33	CEBPB	chr13:63772326-63772639	IMR90	lung:	n/a	n/a
34	CEBPB	chr13:63876910-63877282	IMR90	lung:	n/a	chr13:63877183-63877196 chr13:63877185-63877194 chr13:63876960-63876973 chr13:63877183-63877194 chr13:63877185-63877194 chr13:63877185-63877194 chr13:63877185-63877194
35	CEBPB	chr13:64180178-64180411	IMR90	lung:	n/a	n/a
36	CEBPB	chr13:63930231-63930544	IMR90	lung:	n/a	chr13:63930386-63930403 chr13:63930389-63930400
37	CEBPB	chr13:64171661-64171866	IMR90	lung:	n/a	n/a
38	CEBPB	chr13:64198977-64199235	IMR90	lung:	n/a	chr13:64199079-64199090 chr13:64199079-64199090 chr13:64199080-64199091
39	CEBPB	chr13:64185841-64186143	HepG2	liver:	n/a	chr13:64186008-64186019
40	CEBPB	chr13:63776742-63776947	A549	lung:	n/a	n/a
41	CEBPB	chr13:63890189-63890396	HepG2	liver:	n/a	chr13:63890293-63890304
42	CEBPB	chr13:63836547-63836805	HepG2	liver:	n/a	chr13:63836652-63836663
43	CEBPB	chr13:63869741-63870047	HepG2	liver:	n/a	chr13:63869907-63869918 chr13:63869907-63869920
44	CEBPB	chr13:63995236-63995766	A549	lung:	n/a	chr13:63995336-63995347 chr13:63995317-63995329
45	CEBPB	chr13:63758997-63759239	H1-hESC	embryonic stem cell:	n/a	n/a
46	CEBPB	chr13:63839881-63840177	HepG2	liver:	n/a	n/a
47	CEBPB	chr13:64232307-64232441	HepG2	liver:	n/a	chr13:64232331-64232342
48	CEBPB	chr13:64112921-64113219	IMR90	lung:	n/a	n/a
49	CEBPB	chr13:63874168-63874497	IMR90	lung:	n/a	n/a
50	CEBPB	chr13:63890159-63890458	IMR90	lung:	n/a	chr13:63890293-63890304

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:64009677-64009727	HMEC	breast:	n/a
2	chr13:64189052-64189102	Jurkat	blood:	n/a
3	chr13:64009677-64009727	AoSMC	blood vessel:	n/a
4	chr13:64009677-64009727	HRE	kidney:	n/a
5	chr13:64009677-64009727	HAEpiC	amniotic membrane:	n/a
6	chr13:64189052-64189102	Caco-2	colon:	n/a
7	chr13:64009677-64009727	GM19239	blood:	n/a
8	chr13:64189052-64189102	PrEC	prostate:	n/a
9	chr13:64009677-64009727	GM06990	blood:	n/a
10	chr13:64189052-64189102	AG09309	skin:	n/a
11	chr13:64009677-64009727	HCM	heart:	n/a
12	chr13:64189052-64189102	HepG2	liver:	n/a
13	chr13:64009677-64009727	HNPCEpiC	eye:	n/a
14	chr13:64009677-64009727	Jurkat	blood:	n/a
15	chr13:64189052-64189102	HNPCEpiC	eye:	n/a
16	chr13:64009677-64009727	ovcar-3	ovarian:	n/a
17	chr13:64189052-64189102	H1-hESC	embryonic stem cell:	embryo
18	chr13:64009677-64009727	BJ	skin:	n/a
19	chr13:64009677-64009727	IMR90	lung:	fetal
20	chr13:64009677-64009727	Hepatocyte	liver:	n/a
21	chr13:64009677-64009727	HL-60	blood:	n/a
22	chr13:64189052-64189102	SK-N-SH_RA	brain:	n/a
23	chr13:64009677-64009727	ECC-1	luminal epithelium:	n/a
24	chr13:64009677-64009727	AG09309	skin:	n/a
25	chr13:64189052-64189102	ovcar-3	ovarian:	n/a
26	chr13:64009677-64009727	AG04450	lung:	fetal
27	chr13:64189052-64189102	AG09319	gingival:	n/a
28	chr13:64189052-64189102	ECC-1	luminal epithelium:	n/a
29	chr13:64189052-64189102	GM19239	blood:	n/a
30	chr13:64009677-64009727	HRPEpiC	eye:	n/a
31	chr13:64189052-64189102	HRE	kidney:	n/a
32	chr13:64009677-64009727	HCPEpiC	choroid plexus:	n/a
33	chr13:64009677-64009727	K562	blood:	n/a
34	chr13:64189052-64189102	HPAEpiC	pulmonary alveolar:	n/a
35	chr13:64189052-64189102	U87	brain:	n/a
36	chr13:64009677-64009727	NB4	blood:	n/a
37	chr13:64009677-64009727	GM12878	blood:	n/a
38	chr13:64189052-64189102	HCM	heart:	n/a
39	chr13:64009677-64009727	H1-hESC	embryonic stem cell:	embryo
40	chr13:64189052-64189102	NH-A	brain:	n/a
41	chr13:64189052-64189102	CMK	blood:	n/a
42	chr13:64009677-64009727	HCT-116	colon:	n/a
43	chr13:64189052-64189102	SAEC	small airway:	n/a
44	chr13:64009677-64009727	RPTEC	kidney:	n/a
45	chr13:64189052-64189102	GM12892	blood:	n/a
46	chr13:64189052-64189102	A549	lung:	n/a
47	chr13:64189052-64189102	HL-60	blood:	n/a
48	chr13:64189052-64189102	NHDF-neo	bronchial:	n/a
49	chr13:64189052-64189102	HEK293	kidney:	embryo
50	chr13:64189052-64189102	SKMC	muscle:	n/a

No.	Distal block	Cell Line	Cell type
1	chr13:62693652..62694547-chr13:64030161..64030676,2	MCF-7	breast:
2	chr13:63955263..63957196-chr13:63958888..63961483,2	MCF-7	breast:
3	chr13:64029217..64030812-chr2:218574718..218576354,2	MCF-7	breast:
4	chr13:63976701..63978300-chr13:63983379..63985092,2	MCF-7	breast:
5	chr13:63955263..63957196-chr13:63958888..63961483,2	MCF-7	breast:
6	chr13:63976701..63978300-chr13:63983379..63985092,2	MCF-7	breast:
7	chr12:120076978..120077828-chr13:63812850..63813372,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AL445989.1-2	chr13:64201008-64201079	XLOC_010411
2	lnc-AL445989.1-2	chr13:64207475-64207529	XLOC_010411
3	lnc-AL445989.1-2	chr13:64209594-64209643	XLOC_010411
4	lnc-PCDH20-6	chr13:63886242-63886263	XLOC_010640
5	lnc-PCDH20-6	chr13:63902193-63902270	XLOC_010640
6	lnc-PCDH20-6	chr13:63901377-63901488	XLOC_010640
7	lnc-AL445989.1-2	chr13:64201008-64201079	XLOC_010411
8	lnc-AL445989.1-2	chr13:64209594-64209643	XLOC_010411
9	lnc-PCDH20-6	chr13:63902187-63902270	XLOC_010640
10	lnc-PCDH20-8	chr13:64196102-64196320	XLOC_010642
11	lnc-PCDH20-6	chr13:63901377-63901488	XLOC_010640
12	lnc-PCDH20-9	chr13:64261535-64261688	XLOC_010643
13	lnc-PCDH20-6	chr13:63886242-63886263	XLOC_010640
14	lnc-AL445989.1-2	chr13:64207475-64207529	XLOC_010411
15	lnc-PCDH20-5	chr13:63757234-63757461	XLOC_010639
16	lnc-PCDH20-8	chr13:64204770-64204813	XLOC_010642
17	lnc-PCDH20-9	chr13:64241814-64241972	XLOC_010643
18	lnc-PCDH20-5	chr13:63768623-63768664	XLOC_010639
19	lnc-PCDH20-9	chr13:64241750-64241972	XLOC_010643
20	lnc-PCDH20-7	chr13:64159590-64159812	XLOC_010641
21	lnc-PCDH20-5	chr13:63801112-63801189	XLOC_010639
22	lnc-PCDH20-9	chr13:64241815-64241966	XLOC_010643
23	lnc-PCDH20-7	chr13:64159888-64159977	XLOC_010641
24	lnc-AL445989.1-2	chr13:64208383-64208464	XLOC_010411
25	lnc-AL445989.1-2	chr13:64208379-64208464	XLOC_010411

Variant related genes	Relation type
LINC00376	TF binding region
LINC00376	CpG island
FUNDC2	miRNA target sites
PHTF2	miRNA target sites
DUSP2	miRNA target sites
ZNF71	miRNA target sites

Extended variants
information (count: 7579 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:7579 , 50 per page) page: 1 2 3 4 5 6 7 ... 152

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548071257	chr13:63736348-63736349	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs376113464	chr13:63738013-63738014	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs577509747	chr13:63738176-63738177	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs79913804	chr13:63738200-63738201	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs540055157	chr13:63738207-63738208	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs550371190	chr13:63738266-63738267	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs61954772	chr13:63738284-63738285	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs183071709	chr13:63738310-63738311	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs542356533	chr13:63738331-63738332	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs140420242	chr13:63738377-63738378	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs531278860	chr13:63741238-63741239	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs546181151	chr13:63741251-63741252	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs530676119	chr13:63741272-63741273	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs404075	chr13:63741276-63741277	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs533523699	chr13:63741296-63741297	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs529584775	chr13:63741308-63741309	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs548113027	chr13:63741313-63741314	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs537818200	chr13:63741319-63741320	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs566040203	chr13:63741356-63741357	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs533165288	chr13:63741359-63741360	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs551801305	chr13:63741487-63741488	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs368917972	chr13:63741565-63741566	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs570031438	chr13:63741591-63741592	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs546802022	chr13:63741596-63741597	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs55915303	chr13:63741604-63741605	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs537190609	chr13:63741642-63741643	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs143812863	chr13:63741714-63741715	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs566924779	chr13:63741718-63741719	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs146807515	chr13:63741742-63741743	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs57386605	chr13:63741755-63741756	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs544676413	chr13:63741829-63741830	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs567378192	chr13:63741856-63741857	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs140625088	chr13:63741858-63741859	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs192540697	chr13:63741881-63741882	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs542728153	chr13:63741889-63741890	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs143646288	chr13:63741912-63741913	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs529355094	chr13:63741970-63741971	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs185064939	chr13:63741971-63741972	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs541684591	chr13:63741987-63741988	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs560082778	chr13:63741996-63741997	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs189452603	chr13:63741997-63741998	Enhancers Flanking Active TSS Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs551466714	chr13:63742002-63742003	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs568910994	chr13:63742020-63742021	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs151046545	chr13:63742023-63742024	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs181009736	chr13:63742029-63742030	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs549071079	chr13:63742147-63742148	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs567085223	chr13:63742158-63742159	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs534502316	chr13:63742174-63742175	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs537755446	chr13:63742188-63742189	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs184255904	chr13:63742206-63742207	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Merkel cell carcinoma	19020549	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21858162	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Breast cancer	17393978	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Colorectal cancer	16774939	CNVD
Adenoid cystic carcinoma	17372589	CNVD
abnormal development	18461090	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD

Chromatin state (count:579 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:63735200-63736400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr13:63738000-63738400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr13:63741200-63741600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr13:63741200-63741600	Enhancers	Fetal Brain Female	brain
5	chr13:63741200-63741800	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr13:63741200-63741800	Enhancers	iPS-18 Cell Line	embryonic stem cell
7	chr13:63741600-63741800	Enhancers	iPS-20b Cell Line	embryonic stem cell
8	chr13:63741600-63742000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr13:63741600-63742000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
10	chr13:63741600-63742000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr13:63741600-63742000	Weak transcription	Fetal Brain Female	brain
12	chr13:63741600-63742600	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr13:63741600-63742800	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr13:63741800-63742000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr13:63741800-63742000	Active TSS	Osteobl	bone
16	chr13:63741800-63742200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
17	chr13:63741800-63742200	Enhancers	Breast Myoepithelial Primary Cells	Breast
18	chr13:63741800-63742200	Enhancers	Brain Inferior Temporal Lobe	brain
19	chr13:63741800-63742200	Enhancers	Fetal Lung	lung
20	chr13:63741800-63742400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
21	chr13:63741800-63742400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
22	chr13:63741800-63742400	Active TSS	Brain Anterior Caudate	brain
23	chr13:63741800-63742600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr13:63741800-63742600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr13:63741800-63743000	Enhancers	ES-I3 Cell Line	embryonic stem cell
26	chr13:63741800-63743000	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr13:63741800-63743200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr13:63742000-63742200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
29	chr13:63742000-63742200	Flanking Active TSS	Osteobl	bone
30	chr13:63742000-63742400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr13:63742000-63742400	Enhancers	Brain Substantia Nigra	brain
32	chr13:63742000-63742600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr13:63742000-63742600	Enhancers	Fetal Brain Female	brain
34	chr13:63742200-63742400	Enhancers	H1 Cell Line	embryonic stem cell
35	chr13:63742200-63742400	Enhancers	Osteobl	bone
36	chr13:63742200-63742600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
37	chr13:63742200-63742600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
38	chr13:63742200-63743000	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr13:63742400-63743000	Enhancers	HUES48 Cell Line	embryonic stem cell
40	chr13:63742400-63743400	Enhancers	iPS-18 Cell Line	embryonic stem cell
41	chr13:63742600-63746000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr13:63742800-63749800	Weak transcription	HUES64 Cell Line	embryonic stem cell
43	chr13:63743000-63749800	Weak transcription	HUES48 Cell Line	embryonic stem cell
44	chr13:63743000-63749800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
45	chr13:63743000-63750000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
46	chr13:63743400-63746200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
47	chr13:63744600-63746800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr13:63745800-63746200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr13:63746000-63746400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr13:63746200-63746400	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links